FDA Shifts Its Covid-19 Stance on Vaping, Smoking Impact
- Effect of toxic chemicals from vaping unknown, agency says
- FDA warns smokers may have worse outcomes from virus
This article is for subscribers only.
The U.S. Food and Drug Administration modified its stance on Covid-19 and vaping, saying it has an unknown effect on the risk of the new coronavirus, while warning that smoking can create worse outcomes.
“E-cigarette use can expose the lungs to toxic chemicals, but whether those exposures increase the risk of Covid-19 is not known,” the agency said Wednesday in an emailed response to a question from Bloomberg News.